Evaluated by: David B. Kaminsky, M.D., FIAC, August 8, 2017
Original release date: August 8, 2017
Access to this course expires on: April 8, 2020
CME/SAM 1.5

Faculty: Attilio Orazi M.D., FRCPath. (Engl.)

Learning Objectives:

• Learn a practical approach to splenic neoplastic and pseudotumoral lesions
• Learn how to achieve a careful integration of morphology with clinical and biologic data (e.g., cytogenetics and molecular genetics) to produce a clinically useful integrated report
• Apply an effective diagnostic strategy focused on key ancillary tests of truly diagnostic value

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.